Delivery Order SPE2DB24D2205-SPE2DB24FDVVL
Award Date
6/20/24
Potential Completion Date
6/21/24
Potential Value
$1.9K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product AIMOVIG 140 MG/ML AUTOINJECTORML. The $2,728.01 firm-fixed-price delivery order was awarded on June 28, 2024 by the Defense Logistics Agency (DLA), a defense agency, and has a completion date of July 1, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is a Delivery Order valued at $2,988.96 for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product. The contract was awarded on June 11, 2024 by the Defense Logistics Agency (DLA) Troop Support Medical, a component of the Department of Defense, and has a completion date of June 12, 2024. This Delivery Order is placed against Amerisourcebergen's Indefinite Delivery Contract (IDC) with the DLA,...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division involves the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $3,169.72 firm-fixed-price delivery order was awarded on July 11, 2024 with a completion date of July 12, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the primary vehicle for the company to...
This federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, is a delivery order worth $10,844.44 for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML. The award was made by the Defense Logistics Agency (DLA), a defense agency, and has an ultimate completion date of March 3, 2025. The contract is a firm fixed-price type with no set-aside designation, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML, a pharmaceutical product. The $4,067.19 firm fixed price contract was awarded by the Medical Supply Chain division of the Department of Defense. The contract has an ultimate completion date of July 12, 2024 and was awarded on July 11, 2024. This appears to be a delivery order under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the provision of AIMOVIG 140 MG/ML AUTOINJECTORML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $4,088.07 delivery order is under a larger, single-award Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 between Amerisourcebergen and DLA Troop Support Medical, which expires on December 31, 2025. This IDC serves as the primary vehicle for Amerisourcebergen to...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of AIMOVIG 70 MG/ML AUTOINJECTORML pharmaceutical products. The contract, valued at $12,456.07, is a delivery order under the Defense Logistics Agency (DLA) Troop Support Medical Indefinite Delivery Contract (IDC). This IDC, worth up to $999,999,999 through December 2025, enables the DLA to efficiently procure a wide range of medical commodities, including prescription drugs, to support...
This federal contract award is for a delivery order to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to supply AIMOVIG 140 MG/ML AUTOINJECTORML. The contract, valued at $2,353.16, was awarded by the Defense Logistics Agency (DLA) Troop Support Medical on October 17, 2024, with an ultimate completion date of October 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award is to Amerisourcebergen Drug Corp's Corporate Office division, a major pharmaceutical distribution company, for the supply of AIMOVIG 140 MG/ML AUTOINJECTORML medication to the Defense Logistics Agency (DLA). The delivery order-based contract has a ceiling value of $3,620.96 and an ultimate completion date of July 12, 2024. The contract is a firm fixed price, with no set-aside designation. Amerisourcebergen holds a larger, single-award Indefinite Delivery Contract...
This federal contract award to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, is for the delivery of AIMOVIG 140 MG/ML AUTOINJECTORML pharmaceutical products. The $1,743.29 firm fixed price delivery order was issued by the Defense Logistics Agency (DLA) and has a completion date of March 5, 2024. Amerisourcebergen Drug Corp is the prime contractor on an indefinite delivery contract (IDC) with DLA, valued up to $999,999,999.00 through December 31, 2025. This IDC...